OSI-027 modulates acute graft-versus-host disease after liver transplantation in a rat model-Reference-Cited by-同舟云学术

OSI-027 modulates acute graft-versus-host disease after liver transplantation in a rat model

Published:2017-08-21 Issue:9 Volume:23 Page:1186-1198
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Zhi Xiao¹,Xue Fei²,Chen Wei¹,Liang Chao¹,Liu Hao¹,Ma Tao¹,Xia Xuefeng³,Hu Liqiang¹,Bai Xueli¹,Liang Tingbo¹⁴^ORCID

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery; Hangzhou People's Republic of China

2. Department of Hepatobiliary and Pancreatic Surgery, Henan Provincial People's Hospital; Zhengzhou University People's Hospital; Zhengzhou People's Republic of China

3. Deparment of General Surgery; The Affiliated Drum Tower Hospital of Nanjing University Medical School; Nanjing People's Republic of China

4. Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou People's Republic of China

Funder

National High Technology Research and Development Program 863 of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference33 articles.

1. Acute graft versus host disease following liver transplantation: the enemy within;Taylor;Am J Transplant,2004

2. Liver transplant-associated graft-versus-host disease;Smith;Transplantation,2003

3. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions;Kuball;Transplantation,2004

4. Graft-versus-host disease following living donor liver transplantation;Soejima;Liver Transpl,2004

5. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance;Starzl;Hepatology,1993

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review;Medical Oncology;2021-01

2. Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors;European Journal of Medicinal Chemistry;2020-08